Safety, Tolerability, and Activity of ALV003: Results from Two Phase 1 Single, Escalating-Dose Clinical Trials
Titel:
Safety, Tolerability, and Activity of ALV003: Results from Two Phase 1 Single, Escalating-Dose Clinical Trials
Auteur:
Siegel, Matthew Garber, Mitchell E. Spencer, Andrew G. Botwick, Wendy Kumar, Pawan Williams, Robert N. Kozuka, Kenji Shreeniwas, Revati Pratha, Vijaya Adelman, Daniel C.